Financials

v3.19.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 264 $ 60
Prepaid expenses 22 30
Total Current Assets 286 90
Intangible assets 25,262 25,262
Deposits 12 12
Operating lease right-to-use asset 147 0
Fixed assets, net 0 35
Total Other Assets 25,421 25,309
TOTAL ASSETS 25,707 25,399
Current Liabilities:    
Accounts payable 1,710 1,762
Accrued expenses 2,665 1,455
Deferred rent 8 8
Operating lease liability 147 0
Note payable to related party 0 100
Line of credit 31 31
Convertible debentures 12,170 10,673
Total Current Liabilities 16,731 14,029
Total liabilities 16,731 14,029
Stockholders' Equity:    
Common stock - $0.001 par value; 750,000,000 shares authorized; and 52,644,882 and 50,650,478 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively 53 51
Additional paid-in capital 545,073 540,171
Accumulated deficit (535,984) (528,685)
Noncontrolling interest (169) (169)
Total Stockholders' Equity 8,976 11,370
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 25,707 25,399
Series C    
Stockholders' Equity:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: 1 1
Series J    
Stockholders' Equity:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: $ 2 $ 1

Source

v3.19.2
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating Expenses:        
Research and development $ 154 $ 3,251 $ 988 $ 6,724
Selling, general and administrative 2,125 1,906 5,347 5,593
Total operating expenses 2,279 5,157 6,335 12,317
Loss from Operations (2,279) (5,157) (6,335) (12,317)
Other income (expense)        
Loss on disposal of assets (31) 0 (31) 0
Interest expense (479) (3,924) (933) (6,855)
Total Other Income (Expense) (510) (3,924) (964) (6,855)
Loss before provision for income taxes (2,789) (9,081) (7,299) (19,172)
Provision for income taxes 0 0 0 0
Net loss $ (2,789) $ (9,081) $ (7,299) $ (19,172)
Net loss per common share - basic and diluted $ (.05) $ (0.18) $ (.14) $ (0.38)
Weighted average common shares outstanding - basic and diluted 51,918,252 50,117,977 51,507,849 50,117,977

Source

v3.19.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (7,299) $ (19,172)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 10 2
Stock compensation expense for options and warrants issued to employees and non-employees 3,705 6,489
Amortization of debt discounts 331 6,855
Non-cash interest expense 1,140 0
Loss on disposal of assets 31 0
Amortization of loan costs 0 407
Changes in operating assets and liabilities:    
Other assets 8 0
Accounts payable and accrued expenses 26 (581)
Net cash used in operating activities (2,048) (6,000)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisition of fixed assets 0 (2)
Net cash used in investing activities 0 (2)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from notes payable 2,352 7,055
Loan costs 0 (533)
Repayment of note payable (100) 0
Net cash provided by financing activities 2,252 6,522
Minority Interest 0 0
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 204 520
CASH AND CASH EQUIVALENTS - Beginning of period 60 576
CASH AND CASH EQUIVALENTS - End of period 264 1,096
Supplemental disclosures:    
Interest paid 0 0
Income taxes paid 0 0
Non-Cash Investing and Financing Activities:    
Issuance of common stock upon conversion of convertible notes 1,035 0
Issuance of common stock upon conversion of accrued interest $ 10 $ 0

Source